Member Info for swazers

Excellent post, @H2hooo. Let’s cut through the noise and deal strictly in facts. The statement from Avioxx leadership is unequivocal: Powerhouse Energy’s DMG® technology has demonstrated strong potential for integration into their patented sustainable aviation fuel (SAF) platform. That’s not wishful thinking — it’s direct validation from a serious clean-tech operator with commercial objectives.

The visit to the Bridgend facility is not just a photo-op. It marks the beginning of a real-world RDF-to-syngas testing programme, using live feedstock and operational infrastructure. This is the very kind of empirical, on-site performance data that larger players demand before advancing to commercial agreements.

Let’s be clear: SAF represents one of the most investable decarbonisation verticals in the 2025–2035 horizon, and syngas is a critical input for Fischer–Tropsch fuel synthesis. DMG® has the capability to deliver that syngas from non-recyclable plastics, cleanly and efficiently — that’s exactly what makes it attractive to the aviation supply chain.

So, rather than speculating from the sidelines, Avioxx is on the ground with PHE, validating the system’s real-time outputs. It’s a classic due diligence step prior to deeper integration, and it speaks volumes. Ignore the distractions. This is industrial traction, plain and simple.

⛽️ Strategic Momentum: NEO’s IPO Acceleration Could Be a Major Catalyst for Powerhouse Energy (PHE) 🚀

United H2 Limited’s transition into New Energy Opportunities (NEO) is not just a rebrand. It’s the formalisation of a fast-evolving, acquisition-led clean energy vehicle with a $154M battery manufacturing play, a $102M EV charging business, and most crucially for PHE shareholders — an exclusive relationship with Powerhouse Energy via National H2 (NH2).

📌 Let’s remember: NH2 has the FEED (Front-End Engineering Design) contract with Powerhouse Energy. It’s not speculative — it’s contractual. The FTU at Bridgend in Wales has been developed with precisely this rollout trajectory in mind. With NH2 now folded into NEO’s operational orbit and strategic mandate, PHE’s DMG® technology stands at the forefront of hydrogen-linked infrastructure being prepped for public capital markets.

🔍 Now, NEO is heading to IPO on the ASX in Q4 2025, and every element of the roadmap has been activated:

✅ AGM Resolutions passed with >99.5% approval.

✅ Advisors appointed, pre-IPO raise commencing (not “waiting” for IPO).

✅ Major cornerstone acquisitions are already locked and revenue-generating.

✅ Prospectus and listing mechanics underway with a ticking timetable.

So why does this matter to PHE?

Because PHE is the only partner with patented, licensable plastic-to-hydrogen IP aligned to NH2’s rollout model. The long-term play here is simple: NEO scales across Australia and Asia Pacific, and Powerhouse Energy's tech is licensed across each deployment, turning every plant into a recurring revenue stream.

A successful NEO listing not only validates the clean energy thesis but structurally amplifies the commercial case for Powerhouse Energy’s DMG®. The timeline to value realisation has now materially shortened.

To the naysayers: scroll up and look at the numbers. A $82.6M asset base, independently verified. Over 880 EV charge points, a $17M EBITDA battery play, and a funding mechanism that’s already underway. This isn’t hot air — it’s a structured, mandate-backed commercial vehicle with the infrastructure and ambition to disrupt.

Powerhouse Energy is no longer waiting in the wings. It’s standing directly in the value chain. And the market is waking up.

— Swazers 🧠🔥

#PHE #NEO #Hydrogen #ASXIPO #DMG #CleanEnergy #StrategicMandate #IPRealisation

⛽️ Strategic Momentum: NEO’s IPO Acceleration Could Be a Major Catalyst for Powerhouse Energy (PHE) 🚀

United H2 Limited’s transition into New Energy Opportunities (NEO) is not just a rebrand. It’s the formalisation of a fast-evolving, acquisition-led clean energy vehicle with a $154M battery manufacturing play, a $102M EV charging business, and most crucially for PHE shareholders — an exclusive relationship with Powerhouse Energy via National H2 (NH2).

📌 Let’s remember: NH2 has the FEED (Front-End Engineering Design) contract with Powerhouse Energy. It’s not speculative — it’s contractual. The FTU at Bridgend in Wales has been developed with precisely this rollout trajectory in mind. With NH2 now folded into NEO’s operational orbit and strategic mandate, PHE’s DMG® technology stands at the forefront of hydrogen-linked infrastructure being prepped for public capital markets.

🔍 Now, NEO is heading to IPO on the ASX in Q4 2025, and every element of the roadmap has been activated:

✅ AGM Resolutions passed with >99.5% approval.

✅ Advisors appointed, pre-IPO raise commencing (not “waiting” for IPO).

✅ Major cornerstone acquisitions are already locked and revenue-generating.

✅ Prospectus and listing mechanics underway with a ticking timetable.

So why does this matter to PHE?

Because PHE is the only partner with patented, licensable plastic-to-hydrogen IP aligned to NH2’s rollout model. The long-term play here is simple: NEO scales across Australia and Asia Pacific, and Powerhouse Energy's tech is licensed across each deployment, turning every plant into a recurring revenue stream.

A successful NEO listing not only validates the clean energy thesis but structurally amplifies the commercial case for Powerhouse Energy’s DMG®. The timeline to value realisation has now materially shortened.

To the naysayers: scroll up and look at the numbers. A $82.6M asset base, independently verified. Over 880 EV charge points, a $17M EBITDA battery play, and a funding mechanism that’s already underway. This isn’t hot air — it’s a structured, mandate-backed commercial vehicle with the infrastructure and ambition to disrupt.

Powerhouse Energy is no longer waiting in the wings. It’s standing directly in the value chain. And the market is waking up.

— Swazers 🧠🔥

#PHE #NEO #Hydrogen #ASXIPO #DMG #CleanEnergy #StrategicMandate #IPRealisation

Testpack3 — your latest scattergun rant merely reinforces what’s been obvious for months: you're not here to engage in rational analysis. You're here to disrupt. And you’ve just exposed how weak your position has become.

1️⃣ Avioxx Visit Confirmation

Senior scientists from Avioxx, including Dr Michael Hanc0ck and Dr Steve Wilkinson, visited the Bridgend FTU. They publicly stated that Powerhouse’s DMG® technology shows “very strong potential” for integration into Avioxx’s SAF system. Not speculation. Not hype. It’s already in motion — a real RDF-to-syngas testing programme is underway. Your claim that it’s “just another post” betrays a fundamental misunderstanding of what early-stage validation looks like in cleantech.

2️⃣ “Why no RNS?” – A Classic Red Herring

Not all technical collaborations require an RNS at this phase. The FTU is not a commercial-scale asset; it’s a validation rig — precisely the platform where partnerships are stress-tested. When material milestones are hit (such as commercial terms or tech integration into SAF production), you’ll get your RNS. Until then, obsessing over newswire frequency is just amateur hour.

3️⃣ You Mock Price Action While Ignoring Strategic Progress

Let me be crystal clear: Price is not the arbiter of intrinsic value at this stage of the tech lifecycle. PHE is now showing traction where it matters — IP validation, modular proof of concept, and strategic engagement with companies positioned for scalable impact (see: Avioxx, NH2, Engsolve). You continuously ignore this because your narrative can’t withstand it.

4️⃣ Who’s Laughing at the End?

This tired “we’ll laugh all the way to the bank” refrain isn’t analysis — it’s the language of someone hoping others stay ignorant. But shareholders here aren’t buying your pantomime. They’re watching the maturing ecosystem around DMG®, the emerging tie-ups, and the external parties (from NH2 to Avioxx) stepping into the narrative.

Swazers.

@jancux01, why don't you explain where I'm wrong instead of resorting to your usual personal attacks? The truth is, you are just another shill on this horrendous platform.

WOW, the trolls have made every effort to bump our information to the bottom of the pile. I wonder why?

Excellent post, @H2hooo. Let’s cut through the noise and deal strictly in facts. The statement from Avioxx leadership is unequivocal: Powerhouse Energy’s DMG® technology has demonstrated strong potential for integration into their patented sustainable aviation fuel (SAF) platform. That’s not wishful thinking — it’s direct validation from a serious clean-tech operator with commercial objectives.

The visit to the Bridgend facility is not just a photo-op. It marks the beginning of a real-world RDF-to-syngas testing programme, using live feedstock and operational infrastructure. This is the very kind of empirical, on-site performance data that larger players demand before advancing to commercial agreements.

Let’s be clear: SAF represents one of the most investable decarbonisation verticals in the 2025–2035 horizon, and syngas is a critical input for Fischer–Tropsch fuel synthesis. DMG® has the capability to deliver that syngas from non-recyclable plastics, cleanly and efficiently — that’s exactly what makes it attractive to the aviation supply chain.

So, rather than speculating from the sidelines, Avioxx is on the ground with PHE, validating the system’s real-time outputs. It’s a classic due diligence step prior to deeper integration, and it speaks volumes. Ignore the distractions. This is industrial traction, plain and simple.

let’s get the record straight, testpack3

avioxx & powerhouse energy (phe) – the avioxx post clearly states that dr. michael han**** and dr. steve wilkinson personally visited the bridgend facility to inspect the ftu, describing powerhouse’s dmg® technology as a “strong candidate” for integration into their saf platform. that is not hearsay — it’s first-party confirmation of interest, collaboration, and validation testing. to imply otherwise is to deliberately ignore plain facts.

dmg® relevance to saf – syngas generated via the dmg® process forms a critical input for fischer-tropsch pathways in sustainable aviation fuel. this isn’t speculative. it is an industry-standard process architecture, and avioxx’s ongoing rdf-to-syngas trials reflect exactly that.

roll-out vs testing phase – the reference to 2030 as a rollout horizon is aligned with mass deployment, not pilot validation. phe’s ftu is not speculative; it’s a live engineering rig, which avioxx themselves are now leveraging. this is how innovation enters the commercial pipeline — not through press releases, but real-world, feedstock-driven trials.

market trajectory & hots – multiple parties have already signed heads of terms with phe, disclosed in rns filings. suggesting otherwise is either ignorance or intentional disinformation. hots precede licensing and are standard for tech platforms entering validation and commercialisation phases.

on the share price narrative – price action is not the measure of fundamental value in tech validation stages. the ftu and saf tie-ins are designed to de-risk dmg® for commercial licensing, not create immediate revenue. avioxx’s endorsement is a strategic asset, not a short-term share pump.

in summary, the comment from testpack3 is heavy on provocation and light on facts. let’s not allow this board to be led by those who ignore material updates in favour of personal vendettas.

@Divvyup

Powerhouse Energy’s £150k R&D allocation isn’t a reflection of weakness — it’s a targeted expenditure to extract maximum validation from minimal cost, given that the FTU infrastructure is already built and operational. You don’t throw money at a fully constructed testbed — you deploy capital precisely where it refines outcomes and secures technical milestones.

The FTU isn’t a science experiment. It’s a live demonstrator for commercial-scale output — now being tested by Avioxx for SAF integration, no less. These trials are the final brick in a strategy that was always about proving DMG’s flexibility across multiple verticals: hydrogen, SAF, syngas, and carbon char.

Your implication that this is just "lab success" misses the wider commercial runway. PHE is not chasing an EPC contract; it’s building a licensing and royalty-based IP model, where tech validation leads to high-margin partnerships. This is not a CapEx-driven model, and judging it through that lens reflects a lack of understanding of both the strategy and the sector.

Also, the suggestion that clarity is lacking is outdated. The latest operational updates, Avioxx’s inspection, and the active RDF-to-syngas testing schedule are precisely the commercial clarity long-term holders have waited for. The company has just entered the most critical conversion phase of its history — not one for press puffery, but for tangible delivery.

So let’s drop the tired narrative. This is about execution, not excuses — and from where I’m standing, they’re doing just that.

@h2hooo significant development now confirmed — powerhouse energy group (phe) has formally entered the next stage of technology validation through a direct technical engagement with avioxx, a leading player in the sustainable aviation fuel (saf) space.

dr. michael han**** and dr. steve wilkinson of avioxx have personally inspected the rdf-to-syngas feedstock testing unit (ftu) near bridgend, south wales, developed by powerhouse and engsolve. their findings were conclusive: “we were particularly impressed by the engineering rigour and control infrastructure.”

avioxx has now initiated a testing programme on converting refuse-derived fuel (rdf) to syngas using phe’s proprietary dmg® technology, marking a major validation step towards integration into avioxx’s patented end-to-end saf platform.

why does this matter?

because syngas and carbon-rich coke produced from non-recyclable waste are exactly the kind of feedstocks scalable saf platforms are seeking. if dmg® passes avioxx’s testing protocol — and early signs are promising — it could lead to direct integration into global saf supply chains, unlocking long-term recurring royalties and ip-based revenue.

key points:

✅ strategic validation from sector leaders in saf.

✅ bridgend ftu now serving as a live industrial-grade testbed.

✅ a high-probability path to commercial agreements if syngas purity and system efficiency meet integration thresholds.

✅ real-world application for hard-to-abate sectors — particularly aviation.

this is a textbook example of what ip monetisation looks like in practice: rigorous technical trials → potential licensing → repeatable revenue at scale. the market is still sleeping on this development, but the long game is becoming increasingly clear.

@WordSpaghetti Engsolve isn’t the justification for PHE’s market cap. You’re ignoring the actual business model: PHE isn’t a plant builder or operator, it’s a licensor of patented DMG® waste-to-hydrogen tech. The valuation framework hinges on future royalty income, licensing fees, and strategic technology integration, not short-term cash flow from subsidiaries. The £22m MCAP reflects IP value, not just cash-in-hand.

As for HUI being “not all over the place” — you might want to revisit the recent history. In 24 months, HUI has pivoted from plastic-to-hydrogen → to medical cannabis in Macedonia (OO) → now to InEnTec plasma systems in MENA. That’s three separate industries. Meanwhile, the InEnTec system they’re touting is high capex, unproven at scale, and not aligned with distributed hydrogen goals. And there is no EPC, no FID, no offtake in place on that MENA deal — just a Heads of Terms.

OO isn’t generating revenue for HUI yet. HUI lent it money. They’re hoping for repayment and future dividends, per their own filings. It’s not yet a revenue stream — it’s a risk exposure.

Meanwhile, PHE has a FOAK nearing delivery with NH2, and a policy tailwind from UK hydrogen infrastructure and decarbonisation grants that directly support its modular model. That’s a proper, focused hydrogen tech roadmap. No pivoting. No distractions.

So instead of sniping, perhaps step back and ask: which company has a consistent tech thesis and which one keeps moving the goalposts?

All the best.

Great post, Castlepaul — you’ve nailed many of the core technical and economic limitations of plasma-based systems like InEnTec’s.

To build on this with a bit more technical precision:

CapEx Intensity: Plasma arc gasification is inherently capital-heavy due to the need for high-grade refractory chambers, complex plasma torches, and robust power management systems. Even conservative estimates suggest CapEx per tonne of waste processed is multiples higher than modular systems like PHE’s DMG.

Energy Inefficiency: Maintaining plasma arcs at 3,000°C+ requires sustained high-voltage power. In markets with elevated electricity costs, especially those lacking sovereign power subsidies (unlike parts of MENA), OPEX becomes uncompetitive — and worse, economically fragile for long-term offtake contracts.

Feedstock Rigidity: While plasma systems claim to process diverse waste types, their economics break down with lower-calorific feedstocks. Municipal solid waste and mixed plastics often introduce inefficiencies due to the moisture and variability — conditions under which DMG maintains conversion efficiency via thermal balance and energy recovery.

Commercial Deployability: Unlike PHE’s DMG, which is modular, scalable, and deployable with low site prep overhead, plasma gasification systems need large-scale throughput to justify costs. There’s a reason only a handful of commercial PEM plants exist globally — and they’ve seen long payback cycles and mixed results.

Public Acceptance Risk: Public perception matters. Plasma gasification, despite being distinct from incineration, suffers from the “high heat = incineration = emissions” association in public discourse. By contrast, PHE’s low-temperature, closed-loop thermal conversion system with integral gas cleaning and no combustion avoids triggering that pushback.

Economic Return Window: A key difference is in the return profile — DMG can operate on-site at industrial estates, ports, or waste hubs without grid dependency and generate revenue from both gate fees and H2 production. Plasma systems often require anchor utility contracts or government underwriting to get off the ground.

In short, PHE’s architecture is inherently better aligned with 21st-century hydrogen deployment — distributed, modular, clean, and increasingly backed by regional hydrogen funding like the UK’s £500m package.

Castle — fully agree. PHE’s DMG is the more efficient, sustainable, and commercially realistic pathway.

6. Licensing, IP and Value Capture

HUI doesn’t own the PEM tech — it’s licensed from InEnTec. That means future value extraction is diluted, and they are essentially resellers. PHE, by contrast, owns its DMG tech, patents, and engineering stack outright. It can generate licensing revenue, consulting fees, and engineering income (via Engsolve) — all while retaining control of its IP.

DMG is designed for what the hydrogen economy needs: flexible, scalable, distributed hydrogen and energy from waste, delivered with a self-sustaining and IP-rich model. Plasma systems like PEM are costly, electricity-hungry, and fundamentally misaligned with the realities of decentralised clean energy infrastructure.

The market is waking up. The policy is aligning. Now it's about delivery, and PHE is ahead of the curve

Let’s cut through the fog and look at the hard facts behind the technology differences between Powerhouse Energy’s DMG® system and legacy plasma gasification platforms like InEnTec’s PEM, which Hydrogen Utopia International (HUI) is now pivoting toward in MENA.

1. Capital & Operational Costs

Plasma systems require highly specialised, high-voltage equipment to maintain a stable arc within a plasma reactor. This demands heavy initial capex — often in the range of £80–100m per facility — and significant opex to maintain specialist conditions. DMG, by contrast, is designed to be modular, scalable, and cost-efficient with a lower entry-point capex. For most prospective adopters in markets like Eastern Europe, Southeast Asia, or even UK-based developers, that capex delta is a make-or-break factor.

2. Energy Efficiency

Plasma gasification can operate at temperatures exceeding 2,000°C, but doing so consumes huge amounts of electricity, even in “low-energy” variants like InEnTec’s PEM. DMG utilises a lower-temperature thermal conversion process that requires far less grid input post-start-up, especially when using the system’s own off-gas to fuel its operation. This results in a self-sustaining cycle post-ramp-up — a key design advantage in off-grid or constrained environments.

3. Waste Stream Versatility

Plasma is often praised for its ability to destroy hazardous waste. But that strength comes with a catch: plasma gasification is not optimised for mixed municipal solid waste (MSW) or plastics-to-hydrogen processes where value recovery matters. DMG is engineered specifically for this: recovering hydrogen and high-grade syngas from mixed plastics and biomass streams while capturing carbon, not just destroying it.

4. Commercial Maturity & Market Fit

Despite being around for 20+ years, plasma gasification has struggled to find scalable commercial traction outside niche hazardous waste destruction use cases. Most PEM-type systems are large, centralised, and capital-intensive — the opposite of what most modern circular economy models need. DMG is modular, decentralised, and suited to distributed deployment — perfectly aligned with the UK’s hydrogen cluster model and international demand for localised waste-to-energy hubs.

5. Emissions, Perception & Political Fit

Plasma systems still carry public resistance due to their perceived similarity to incineration, especially where transparency on emissions, off-gas handling, and vitrification isn’t clear. DMG, on the other hand, produces virtually no emissions, vitrifies residuals into usable construction-grade materials, and has already passed key regulatory scrutiny in the UK. In terms of ESG credentials, DMG is streets ahead. (Continue next page).....

@Panman, ironically, you just confirmed the core concern yourself — HUI’s financial sustainability is explicitly tied to repayments and dividends from Ohrid Organics. That is not fabrication; that’s exactly the fragility being highlighted.

You claim “OO see no issue,” but there are no audited schedules, no declared dividend policy, no fixed repayment dates — just assumptions. Even the annual report’s own wording uses forward-leaning conditional language. That’s not commercial certainty — it’s dependency on a third-party business that hasn’t published independently verified financials or GMP certification.

And citing “recent contract wins” is hand-waving unless they’re tied to confirmed, recurring revenue. HUI’s balance sheet still shows negative operating cash flow and a reliance on equity raises — that’s not up for debate, that’s their own filing.

You can call it trolling, but calling out weak fundamentals backed by company-published data is just proper analysis. Filtering won’t change reality.. Swazers.

@Panman, while it's easy to lift a line from the going concern note, it's important not to misrepresent its meaning.

Yes, the auditors reference anticipated positive cash flow — but that’s entirely contingent on repayments and dividends from Ohrid Organics, which, as of now, remain unproven and speculative. There’s no verifiable schedule, no dividend policy in place, and no completed transaction publicly confirmed with GMP certification still pending.

Also, let’s not ignore that the cash position as of year-end was under £270k — and that was before the recent placing. That places them on extremely thin operational footing. Any talk of sustainable cash flow needs to be grounded in secured revenue streams, not forward-looking assumptions tied to untested assets.

Auditors don’t audit predictions — they test whether the assumptions made by management are reasonable, not guaranteed. And as you know, reliance on a single investment (OO) for solvency is inherently risky, particularly given how volatile the medical cannabis market is globally, and how far from operational maturity this particular play appears to be.

So yes, the note exists — but treating it like a confirmation of cash flow strength is misleading at best.

Spot on, @Castlepaul13.

The market reaction post-HOTs says a lot — no signed EPC, no funding secured, no regulatory greenlight, and yet certain posters are spinning it like it’s project-finance ready. The reality is as you say: this is early-phase positioning, not execution. HOTs can take years to progress into anything commercially meaningful, especially when the tech being deployed requires bespoke, high-CAPEX infrastructure and region-specific power economics to work at all.

You're also right to point out that PHE is already well ahead — FTU is operational, Engsolve is profitable, and real FEED data is being delivered. That’s the difference between live engineering progress and a press release pipeline.

On the point of Poland and Ireland, we all want HUI to succeed where they’re genuinely aligned with PHE’s tech. But we’ve also seen multiple pivots now — from cannabis to plasma, which leaves question marks over focus. The DMG tech has a clear licensing pathway and a modular rollout model that aligns directly with EU and UK hydrogen policy. That’s the real asset here.

Appreciate your clarity, as always. It’s voices like yours that help keep the board grounded in facts rather than noise. Time will indeed tell. Swazers.

""Dr Al - get back to the PHE board or I'll start posting on that one - and I am 100% sure the £22m MCAP is far, far too high for Engsolve. So, what's it gonna be? You are also quite wrong to think HUI are all over the place. The OO is already bringing in revenues to OO and the preIPO is either closed or if you're lucky it may still be open to further investors, the MENA deal will progress the hydrogen modus operandi and bring in revenues.PHE however... when's that £20m revenue coming in again to support the MCAP?""

Let's handle this utter nonsense with actual facts and reality.

1️⃣ The OO revenues you reference are not hydrogen project revenues. They relate to a private cannabis acquisition not yet completed, per HUI's own RNS. It has no bearing on hydrogen IP or deployment.

2️⃣ The MENA Heads of Terms is just that — Heads of Terms. No signed EPC contract, no funded plant, no construction underway. Market reaction last week confirms the market sees this clearly.

3️⃣ The pre-IPO talk is aspirational — HUI itself disclosed that it required a fund raise just to support ongoing operations. That is not an indication of fundamental traction; it’s dilution management.

4️⃣ Meanwhile, PHE has:

✅ A fully operational Feed Testing Unit generating revenue.

✅ Engsolve is delivering record engineering revenues YTD.

✅ US and EU patents granted protecting unique IP.

✅ National H2 licensing path progressing — aligned with UK hydrogen policy.

5️⃣ £20m revenue? No one credible has ever forecast that as immediate. PHE is building a modular licensing model — this is an IP and engineering-led scaling path, not a linear plant-by-plant revenue ramp.

👉 Summary: HUI currently has zero operating hydrogen plants and is pivoting between sectors. PHE is progressing validated IP, engineering revenues, and licensing. Apples and oranges. Regards, Swazers.

The weekly close with HUI, most of the gains are now eradicated. The pump becomes the dump. https://www.tradingview.com/x/QJb2RDfO/

1️⃣ HUI currently has no operational hydrogen plants or revenue-producing hydrogen units that are built or running. The recent RNS refers to Heads of Terms — not signed project contracts or funded builds.

2️⃣ The InEnTec technology is not HUI’s IP. The European rights to InEnTec are already held by Plagazi. HUI’s licence is restricted to MENA only and is not exclusive globally. No commercial plants from this deal yet exist.

3️⃣ RNS disclosures confirm a recent placing. This provided short-term liquidity but also added dilution. The subsequent price spike and fast reversal suggest placing stock has been sold into the market, aligning with the chart.

4️⃣ The company has pivoted multiple times. In recent years, HUI has announced interest in multiple sectors (plastics-to-hydrogen, cannabis, various regions). Core execution against these ambitions remains unproven.

5️⃣ Balance sheet remains fragile.HUI’s own filings show the business remains reliant on raises — it is not yet cash-generative. That makes any valuation surge without matching fundamental delivery unsustainable.

👉 The chart is simply reflecting these realities: news-driven spike, followed by market recognition that fundamentals have not materially changed.

As ever, facts matter. The market is signalling caution here for good reason.

@testpack3 Let’s be very clear — personal attacks and Protos Park myths are all this poster has left, because the fundamentals of PHE no longer suit his narrative.

This isn’t accidental. It’s calculated. And it follows the same pattern every time: Discredit Bob Smith — why? Because Bob brings informed, detailed research that certain actors want silenced.Obsess about past projects — why? Because they can’t counter the current IP strength, revenue progress, or market alignment of PHE.Create noise and diversion — why? To drown out serious investors who understand the licensing model PHE is now pursuing.

Here’s what the trolls can’t change with all their bile: The DMG process is validated and protected by international patents. The FTU is operational and delivering results . Engsolve is generating revenue and expanding its commercial footprint.NH2 and Ballymena are progressing toward their first commercial licensing deals. The UK government is now explicitly backing distributed hydrogen networks — a direct strategic fit for DMG.

No amount of Protos Park nostalgia or avatar conspiracy theories will alter these facts. The market is evolving. PHE is evolving. Certain posters are stuck in the past for a reason — because they can’t win the argument on fundamentals today.

As for attacking Bob? That speaks volumes. When trolls can’t refute your facts, they attack your name. That tells you who is holding the stronger hand — and it’s not them. We see you. We’re not fooled. And we’re moving forward with facts, not fiction. @testpack3 has been jealous of Bob Smith for years and it shows, massively.

Https://www.gov.uk/government/news/500m-boost-for-hydrogen-to-create-thousands-of-british-jobs This is very good news for PHE’s medium- and long-term positioning.

The £500m hydrogen transport & storage investment is a strong macro signal that supports exactly the kind of distributed hydrogen production PHE is developing through DMG. Regional hubs, industrial decarbonisation, and local energy resilience are all aligned with DMG’s architecture. This strengthens the commercial potential of PHE’s roadmap and makes its IP even more strategically valuable as the UK market scales up.

1. Transport and Storage Network. The funded infrastructure will finally build out the missing midstream layer, which is what has held back distributed hydrogen production models like DMG. Once regional H2 networks are in place, DMG modules become instantly more bankable for project developers.

Can be deployed closer to waste sources, knowing they can feed H2 into the grid or storage. Become highly attractive for "plug and play" small-to-medium projects that can now hook into funded networks. This reduces risk and CapEx barriers for PHE licensees → critical in tipping early commercial projects forward.

2. Demand Pull — Industrial Decarbonisation. The announcement explicitly calls out industrial sectors: steel, glass, chemicals, and ceramics. These are ideal off-take targets for DMG-based. These sectors do not require ultra-pure PEM-fuel-cell-only hydrogen. They value local, low-carbon H2 with strong carbon accounting — exactly where DMG performs well. This creates a high-margin demand pool in PHE’s key markets.

3. Distributed Production Is Implicitly Favoured. The reference to "regional hubs" and "local economies" is critical. It signals that the government is not backing only giant centralised electrolyser plants.PHE’s distributed, modular model is built for exactly this market, where H2 is produced near the waste stream and consumed regionally.

4. PHE Partner Leverage. National H2 and Ballymena are already aligned to this policy direction. The policy de-risks their licensing model: It makes their projects more likely to attract debt financing. It makes them more credible to corporate offtakers.NH2’s timing could become perfect — if FEED converts → first licensing → plug into this government-supported infrastructure build.

5. IP Positioning.PHE’s patents now cover both the production architecture and its integration into waste-to-hydrogen pathways that match this policy. The stronger the policy environment → the stronger the IP monetisation potential → the more valuable the DMG stack becomes.

PHE’s DMG system is designed for local, modular hydrogen production from waste, not giant centralised plants. The fact that the government is now backing regional hubs and supply chain growth lines up perfectly with this model. This strengthens the case for PHE’s long-term licensing model.